Search
Search Results
-
Should additional value elements be included in cost-effectiveness analysis in pharmacoeconomic evaluation: a novel commentary
In recent years, international academics recognized that quality-adjusted life-years (QALYs) may not always fully capture the benefits produced by an...
-
Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran
PurposeThe higher costs of insulin analogs including short-acting insulin aspart (IAsp) and long-acting insulin glargine (IGla) have restricted their...
-
Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version
The first version of the pharmacoeconomic (PE) guidelines was published in South Korea in 2006. Despite its first revision in 2011, there were still...
-
Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study
IntroductionA growing number of biologics have recently been approved in China for psoriasis treatment, and some of these are eligible for Chinese...
-
Pharmacoeconomic Assessment of Antiallergic Drugs by Comparing Serum Immunoglobulin E Level as a Diagnostic and Monitoring Indicator of Allergic Rhinitis in Rural Population of India
Allergic rhinitis (AR) is a chronic inflammatory disease induced by IgE mediated reaction and identified clinically by presence of nasal discharge,...
-
Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial
BackgroundEmpirical use of pharmacogenetic test(PGT) is advocated for many drugs, and resource-rich setting hospitals are using the same commonly....
-
Development of a pharmacoeconomic registry: an example using hormonal contraceptives
BackgroundDisease-specific registries, documenting costs and probabilities from pharmacoeconomic studies along with health state utility values from...
-
The effectiveness and pharmacoeconomic study of using different corticosteroids in the treatment of hypersensitivity pneumonitis
PurposeInterstitial lung diseases (ILDs) are caused by inflammation and/or fibrosis of alveolar walls resulting in impaired gas exchange....
-
Clinical and pharmacoeconomic impact of subgroup analysis in onco-hematological patients
Subgroup analysis evaluates a health intervention in subpopulations according to a characteristic or factor. It can be useful for generating new...
-
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
The use of multiple cost-effectiveness thresholds in pharmacoeconomic evaluation is a hotly debated topic in the international academic community....
-
Systematic review of the economic evaluation model of assisted reproductive technology
BackgroundWith the increasing demand for fertility services, it is urgent to select the most cost-effective assisted reproductive technology (ART)...
-
Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
Pharmacometrics is the science of quantifying the relationship between the pharmacokinetics and pharmacodynamics of drugs in combination with disease...
-
A Review of Utility Measurement Methods Used in Pharmacoeconomic Submissions to HIRA in South Korea: Methodological Consistency and Areas for Improvement
Pharmacoeconomic (PE) guidelines, first published in 2006 and later updated in 2011, were developed to guide the preparation and submission of PE...
-
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature
Cost-effectiveness analyses commonly use population or sample averages, which can mask key differences across subgroups and may lead to suboptimal...
-
Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system
ObjectivesTo evaluate the cost-effectiveness of biologics and methotrexate (MTX) for rheumatoid arthritis (RA) using the number needed to treat (NNT)...
-
Systematic Review and Quality Assessment of Health Economic Evaluation Studies (2007–2019) Conducted in South Korea
BackgroundSouth Korea formally adopted economic evaluation in December 2006 to aid drug reimbursement decision-making. While this policy change is...
-
National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison
Background and ObjectivesGlobally, a number of countries have developed guidelines that describe the design and conduct of economic evaluations as...
-
Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results
BackgroundHealth state utility values (HSUVs) identified from utility elicitation studies are widely used in pharmacoeconomic evaluations for chronic...
-
Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis
Background Few regimens for non-small cell lung cancer (NSCLC) with leptomeningeal metastases (LM) patients exist up to date, most with low efficacy....
